Literature DB >> 10821972

Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus.

S A Tsarev1, M L Sanders, D W Vaughn, B L Innis.   

Abstract

Phylogenetic analysis was performed for different genome regions of Japanese encephalitis virus (JEV). Similar genetic groupings were identified for all analyzed genome regions including complete genomes. More extensive analysis was performed for 92 isolates (complete envelope sequences) available in the GenBank. Results of phylogenetic analysis were compared with those performed for human positive strand RNA viruses with well characterized serotypes - poliovirus (PV) and dengue virus (DEN). The observed level of the JEV inter-genotype diversity was much less than that observed across PV and DEN serotypes and was consistent with the genetic diversity observed within PV or DEN serotypes. This genetic analysis supports the contention that all known JEV isolates comprise a single serotype.

Entities:  

Mesh：

Year:  2000        PMID： 10821972     DOI： 10.1016/s0264-410x(00)00039-6

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  12 in total

Review 1.  Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.

Authors:  Nagendra R Hegde; Milind M Gore
Journal:  Hum Vaccin Immunother       Date:  2017-02-22       Impact factor: 3.452

2.  Expression of recombinant envelope protein of Japanese encephalitis virus YL strain in Escherichia coli possesses hemagglutination activity.

Authors:  S-O Chen; T-H Tsai; T-J Chang; M-L Wong; H-P Su; J-J Liu
Journal:  Virus Genes       Date:  2004-03       Impact factor: 2.332

Review 3.  Zoonotic encephalitides caused by arboviruses: transmission and epidemiology of alphaviruses and flaviviruses.

Authors:  Yun Young Go; Udeni B R Balasuriya; Chong-Kyo Lee
Journal:  Clin Exp Vaccine Res       Date:  2013-12-18

4.  Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4.

Authors:  Gregory D Gromowski; Cai-Yen Firestone; Christopher T Hanson; Stephen S Whitehead
Journal:  Vaccine       Date:  2014-03-31       Impact factor: 3.641

Review 5.  The present and future of veterinary vaccines for Japanese encephalitis in Korea.

Authors:  Jin-Ju Nah; Dong-Kun Yang; Ha-Hyun Kim; Jae-Young Song
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

6.  Heterologous Protection against Asian Zika Virus Challenge in Rhesus Macaques.

Authors:  Matthew T Aliota; Dawn M Dudley; Christina M Newman; Emma L Mohr; Dane D Gellerup; Meghan E Breitbach; Connor R Buechler; Mustafa N Rasheed; Mariel S Mohns; Andrea M Weiler; Gabrielle L Barry; Kim L Weisgrau; Josh A Eudailey; Eva G Rakasz; Logan J Vosler; Jennifer Post; Saverio Capuano; Thaddeus G Golos; Sallie R Permar; Jorge E Osorio; Thomas C Friedrich; Shelby L O'Connor; David H O'Connor
Journal:  PLoS Negl Trop Dis       Date:  2016-12-02

7.  Persistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization 5 Years After JE-CV Immunization.

Authors:  Emmanuel Feroldi; Mark Boaz; Sutee Yoksan; Kulkanya Chokephaibulkit; Usa Thisyakorn; Chitsanu Pancharoen; Céline Monfredo; Alain Bouckenooghe
Journal:  J Infect Dis       Date:  2017-01-15       Impact factor: 5.226

8.  Protective efficacy of Zika vaccine in AG129 mouse model.

Authors:  K Sumathy; Bharathi Kulkarni; Ravi Kumar Gondu; Sampath Kumar Ponnuru; Nagaraju Bonguram; Rakesh Eligeti; Sindhuja Gadiyaram; Usha Praturi; Bhushan Chougule; Latha Karunakaran; Krishna M Ella
Journal:  Sci Rep       Date:  2017-04-12       Impact factor: 4.379

9.  Japanese encephalitis virus: A multi-epitope loaded peptide vaccine formulation using reverse vaccinology approach.

Authors:  Supriyo Chakraborty; Antara Barman; Bornali Deb
Journal:  Infect Genet Evol       Date:  2019-11-06       Impact factor: 3.342

Review 10.  Japanese encephalitis: the virus and vaccines.

Authors:  Sang-Im Yun; Young-Min Lee
Journal:  Hum Vaccin Immunother       Date:  2013-10-25       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.